Why Holding Jardiance Before Surgery is Crucial: A Comprehensive Guide
#Holding #Jardiance #Before #Surgery #Crucial #Comprehensive #Guide
Why Holding Jardiance Before Surgery is Crucial: A Comprehensive Guide
Alright, let's talk about something incredibly important, something that, frankly, doesn't get enough airtime in casual conversations but can make all the difference between a smooth recovery and a truly nasty complication: why you absolutely must hit pause on your Jardiance before surgery. If you're on this medication, or know someone who is, and surgery is on the horizon, this isn't just medical advice; it's a plea for informed caution. We’re not just talking about a minor tweak to your routine here; we’re delving into a critical safety measure that protects your body when it’s at its most vulnerable.
You see, modern medicine is a marvel, and drugs like Jardiance (empagliflozin) have revolutionized how we manage chronic conditions, offering benefits far beyond what we initially imagined. But here's the kicker: these powerful medications come with equally powerful effects, and when you introduce the physiological maelstrom of surgery, what's usually beneficial can suddenly turn into a serious liability. It’s like having a precision tool that works wonders in one environment, but in another, more volatile setting, it could inadvertently cause damage. My goal here isn't to scare you, but to empower you with knowledge, to peel back the layers of medical jargon and reveal the very real, very serious reasons behind this crucial instruction. So, settle in, because we're going to break down the 'why' behind holding Jardiance, making sure you understand every intricate piece of this vital puzzle.
Understanding Jardiance: Beyond Blood Sugar Control
When we talk about Jardiance, most people immediately think "diabetes medicine." And they're not wrong, but that's just the tip of a very fascinating iceberg. This drug, and others in its class, represent a significant leap forward, offering benefits that extend far beyond simply lowering blood glucose. Understanding its full scope is the first step in appreciating why it needs special consideration when your body is about to undergo the monumental stress of surgery. It’s not just a sugar pill; it’s a systemic modulator, and that’s where the complexity, and the perioperative risks, truly begin to emerge.
What is Jardiance (Empagliflozin)?
Let's get down to brass tacks. What exactly is Jardiance? Its generic name is empagliflozin, and it belongs to a class of drugs known as SGLT2 inhibitors. Now, "SGLT2 inhibitor" might sound like a mouthful of medical jargon, but let's unpack it because understanding this mechanism is absolutely foundational to grasping why holding it before surgery is non-negotiable. SGLT2 stands for Sodium-Glucose Co-Transporter 2. These transporters are located predominantly in the kidneys, specifically in the proximal tubules, and their job is pretty straightforward: reabsorb glucose back into the bloodstream after it's been filtered out. Think of them as tiny, efficient vacuum cleaners for glucose, making sure your body doesn't waste precious energy by peeing it out.
Jardiance, as an SGLT2 inhibitor, does exactly what its name implies: it inhibits these transporters. By blocking SGLT2, it essentially tells those tiny glucose vacuum cleaners to take a break. The result? More glucose stays in the urine and is expelled from the body. This mechanism is elegantly simple yet profoundly effective for lowering blood glucose levels in people with Type 2 Diabetes. Instead of focusing on insulin production or sensitivity, it tackles glucose removal directly, independent of insulin pathways to a significant degree. It was a game-changer when it first came out, offering a novel way to manage hyperglycemia without some of the traditional side effects associated with other diabetes medications, like weight gain or increased risk of hypoglycemia on its own.
But here’s where it gets even more interesting, and where the "beyond blood sugar control" part truly shines. While initially approved for Type 2 Diabetes, subsequent research unveiled a stunning array of cardiovascular and renal benefits. It turns out that by promoting glucose excretion and having a mild diuretic effect, Jardiance also reduces fluid volume, lowers blood pressure, and somehow, through mechanisms still being fully elucidated, directly protects the heart and kidneys. This led to its approval for reducing the risk of cardiovascular death in adults with Type 2 Diabetes and established cardiovascular disease, and later, for reducing the risk of cardiovascular death and hospitalization for heart failure in adults with any form of heart failure (with reduced or preserved ejection fraction). More recently, it's gained approval for slowing the progression of chronic kidney disease (CKD) and reducing the risk of cardiovascular death and hospitalization in adults with CKD, regardless of diabetes status.
So, what is Jardiance? It's a medication that has evolved from a diabetes drug into a multifaceted protector of the heart and kidneys, working primarily by encouraging the kidneys to excrete excess glucose and sodium. This broad spectrum of action is precisely what makes it so valuable for millions of patients, but it’s also the very reason we need to treat it with extreme caution when the body is about to enter the highly artificial and stressful environment of a surgical procedure. Its systemic effects are powerful, and in the wrong context, those powers can be detrimental rather than beneficial.
Keyword Focus: what is Jardiance, empagliflozin, SGLT2 inhibitor mechanism, Jardiance uses.
The Critical Perioperative Period: Why Medications Change
Now that we understand the multifaceted nature of Jardiance, let's pivot to the equally complex landscape of the perioperative period – that critical window encompassing the time before, during, and immediately after surgery. This isn't just about the surgeon's skill or the anesthesiologist's precision; it's about preparing your entire body for a significant physiological challenge. And a huge part of that preparation involves a meticulous review and often, adjustment, of your regular medication regimen. It’s not a one-size-fits-all approach; it’s a finely tuned symphony where every instrument needs to be in harmony.
Think about it: your body is about to undergo a controlled trauma. You'll likely be asked to fast (NPO status – nil per os, or "nothing by mouth") for many hours, which immediately throws your usual metabolic rhythm into disarray. Then comes the anesthesia, a profound alteration of your consciousness and physiological responses, followed by the actual surgical procedure, which involves tissue injury, blood loss, fluid shifts, and an intense inflammatory response. Each of these components places tremendous stress on your organ systems – your heart, lungs, kidneys, and endocrine system are all working overtime to maintain homeostasis in the face of this onslaught.
This is precisely why perioperative medication management isn't just a suggestion; it's a non-negotiable cornerstone of patient safety. Medications that are perfectly safe and beneficial in your daily life can become dangerous when your body is under surgical stress. For instance, blood thinners need to be stopped to prevent excessive bleeding. Certain blood pressure medications might be held to avoid precipitous drops during anesthesia. Insulin doses often need to be drastically adjusted because of fasting and the body's stress response. The goal is to minimize risks, ensure the body is as stable as possible, and prevent adverse drug interactions or exacerbation of surgical complications.
The NPO status, in particular, is a major disruptor. Without food or drink, your body's usual glucose supply dwindles, and it starts tapping into stored energy. This can lead to changes in blood sugar, electrolyte imbalances, and fluid status. Add to this the effects of anesthesia, which can suppress organ function, alter blood flow, and affect how drugs are metabolized and excreted. Then, during surgery itself, fluid shifts are common, and the body's stress hormones (like cortisol and glucagon) surge, further complicating metabolic control. It's a delicate balancing act, and every medication you take has the potential to tip that balance one way or another.
Pro-Tip: The "Stress Response" Unveiled
When your body goes through surgery, it mounts a full-blown "stress response." This isn't just a feeling; it's a cascade of hormonal changes. Your adrenal glands pump out cortisol and adrenaline, your liver releases stored glucose, and your body enters a catabolic state, breaking down tissues for energy. This response is designed to help you survive acute injury, but it also makes metabolic control – especially blood sugar – much harder to manage. Medications that normally help regulate these systems need to be carefully re-evaluated in this high-stakes environment.
Keyword Focus: perioperative medication management, medication review before surgery, NPO status surgery.
The Primary Dangers: Why Jardiance Poses Unique Risks
Now, let's get to the heart of the matter. Why is Jardiance, specifically, such a concern in the perioperative period? It's not just another medication; its unique mechanism of action, which is so beneficial in chronic management, creates a specific constellation of risks that can be particularly insidious and dangerous around the time of surgery. We're talking about threats that are often silent, difficult to diagnose, and can rapidly escalate into life-threatening emergencies if not anticipated and prevented. This isn't fear-mongering; it's a stark reality that medical professionals have learned through experience and rigorous study.
The Silent Threat: Euglycemic Diabetic Ketoacidosis (eDKA)
This, my friends, is the big one. The primary and most severe risk associated with Jardiance and other SGLT2 inhibitors in the perioperative setting is Euglycemic Diabetic Ketoacidosis, or eDKA. If you’ve heard of DKA before, you likely associate it with sky-high blood sugar levels, often seen in Type 1 diabetics who haven't taken enough insulin. But eDKA is a treacherous beast because it defies that expectation: severe ketoacidosis occurs despite normal or only mildly elevated blood glucose levels. This makes it incredibly difficult to diagnose, as the usual red flag – hyperglycemia – is absent. And that, right there, is why it's so dangerous.
Imagine a patient coming out of surgery. They're feeling unwell, maybe a bit nauseous, tired, perhaps breathing a little faster. The medical team checks their blood sugar, and it's 150 mg/dL – perfectly acceptable, maybe even good for someone just out of an operation. Everything seems fine on that front. But beneath the surface, a storm is brewing. Their body is producing dangerously high levels of ketones, their blood is becoming acidic, and their cells are starving for energy despite the presence of glucose. This discrepancy, this "normal blood sugar ketoacidosis," is what makes eDKA such a diagnostic nightmare and why it can lead to delayed treatment and worse outcomes.
I remember a case, not specifically with Jardiance but an SGLT2 inhibitor, where a patient undergoing a routine orthopedic procedure started feeling progressively worse post-op. Vague symptoms, nothing screaming "DKA" because their blood glucose was consistently within a reasonable range. It took an astute resident, who had recently attended a lecture on SGLT2 inhibitors and eDKA, to suggest checking ketones. Lo and behold, they were profoundly elevated. The patient was in severe ketoacidosis, and we had almost missed it because we were focused on the wrong indicator. That experience hammered home the insidious nature of eDKA and reinforced the absolute necessity of holding these medications.
The consequences of untreated DKA, whether euglycemic or not, are severe. It can lead to cerebral edema (brain swelling), acute kidney injury, cardiac arrhythmias, and even death. The body's delicate acid-base balance is thrown into chaos, and every major organ system is affected. For someone recovering from surgery, whose body is already under immense strain, developing eDKA is an additional, often overwhelming, burden that can derail recovery and create a cascade of further complications. It's a silent threat that demands our utmost respect and proactive prevention.
Keyword Focus: euglycemic DKA Jardiance, DKA SGLT2 inhibitors, normal blood sugar ketoacidosis.
Pathophysiology of eDKA with Jardiance
To truly understand why Jardiance can unleash eDKA, we need to dive a little deeper into the biochemical ballet happening inside your body. It's a complex interplay of hormones and metabolic pathways, all twisted by the presence of the drug and the stress of surgery. Jardiance, by design, messes with your body's glucose handling, and when you combine that with fasting and surgical stress, you create a perfect storm for ketone overproduction.
Here’s the breakdown of how Jardiance contributes to eDKA:
- Increased Glucagon and Enhanced Ketogenesis: Jardiance, by lowering blood glucose through renal excretion, subtly signals to the body that glucose might be scarce. This triggers an increase in glucagon, a hormone that opposes insulin. Glucagon's job is to raise blood sugar, but it also promotes the breakdown of fats into fatty acids, which are then converted into ketones by the liver. Normally, insulin would suppress this process, but SGLT2 inhibitors can shift the insulin-to-glucagon ratio, favoring glucagon's effects. So, even with normal glucose, the body is primed for ketone production.
- Reduced Glucose Excretion (Paradoxically as Glucose Levels Drop): While Jardiance increases glucose excretion when blood sugar is high, its effect on overall glucose balance can become paradoxical during fasting. As you fast before surgery, your blood glucose naturally starts to drop. The body usually responds by conserving glucose and switching to fat metabolism. However, Jardiance keeps those SGLT2 transporters inhibited, meaning that even at lower glucose levels, some glucose is still being lost through the urine. This continuous glucose loss, combined with fasting, can push the body further into a state where it believes glucose is severely deficient, even if it's not dangerously low in the blood. This prompts an even greater reliance on fat breakdown and ketone production as an alternative fuel source.
- Volume Depletion: As we'll discuss more, Jardiance has a diuretic effect, meaning it makes you pee out more fluid. This leads to a reduction in circulating blood volume. Dehydration, even mild, can concentrate blood and further exacerbate the metabolic stress, making the body more susceptible to acidosis and increasing the risk of ketone formation. A dehydrated body is a stressed body, and a stressed body is more prone to eDKA.
- Inhibition of Ketone Excretion: Some research suggests that SGLT2 inhibitors might also interfere with the kidney's ability to excrete ketones, potentially contributing to their accumulation in the blood. While the primary driver is increased production, reduced clearance could play a secondary role in worsening the acidosis.
Keyword Focus: Jardiance DKA mechanism, SGLT2 eDKA pathophysiology, glucagon SGLT2.
Dehydration and Hypovolemia Risks
Beyond the terrifying prospect of eDKA, Jardiance carries another significant risk that is often overlooked but profoundly important in the perioperative context: dehydration and hypovolemia. You might think, "Oh, a little less fluid, what's the big deal?" But in the delicate balance of surgery, even mild dehydration can have severe repercussions, and Jardiance actively works to tip that balance.
Remember how Jardiance helps lower blood sugar by making you excrete glucose in your urine? Well, glucose is an osmotic agent, meaning it pulls water with it. So, when you're peeing out more glucose, you're also peeing out more water. This is a deliberate and desired effect of the drug, contributing to its blood pressure-lowering and heart failure benefits. It’s a chronic, mild diuretic effect that, under normal circumstances, your body can usually compensate for by increasing thirst and fluid intake.
However, the perioperative period is anything but normal circumstances. You're typically NPO for hours before surgery, meaning no food, no water. This alone puts you at risk of mild dehydration. Then you add Jardiance, which has been steadily encouraging your kidneys to shed fluid for days or weeks leading up to the procedure. So, you're starting the race already behind on hydration. During surgery, there are further fluid shifts. Anesthesia can cause vasodilation (widening of blood vessels), making it harder for your body to maintain blood pressure. Surgical incisions and exposure of tissues can lead to "third spacing," where fluid moves out of your blood vessels and into interstitial spaces, essentially becoming unavailable to circulate. Blood loss, even minor, also contributes to volume depletion.
When you combine Jardiance's diuretic effect with NPO status and the inherent fluid dynamics of surgery, you create a recipe for significant volume depletion and hypovolemia (low blood volume). This can lead to a dangerously low blood pressure, making it difficult for the anesthesiologist to maintain adequate perfusion to vital organs. Imagine trying to water a garden with a hose that has very little pressure – some areas just won't get enough water. In your body, this translates to reduced blood flow to organs like the kidneys, brain, and heart, which are already under stress. The risk of fainting, dizziness, and overall instability increases dramatically. Therefore, understanding Jardiance dehydration and volume depletion SGLT2 is paramount.
Insider Note: The Anesthesiologist's Headache
From an anesthesiologist's perspective, a hypovolemic patient is a nightmare. They are incredibly sensitive to anesthetic agents, which often cause blood pressure drops. Trying to maintain adequate blood pressure and organ perfusion in someone who is already volume-depleted is like walking a tightrope. It requires constant vigilance, rapid fluid administration, and sometimes vasopressors, all of which add layers of complexity and risk to the procedure. Holding Jardiance removes a major variable from this already challenging equation.
Keyword Focus: Jardiance dehydration, volume depletion SGLT2, hypovolemia surgery.
Acute Kidney Injury (AKI) Exacerbation
Building directly on the risks of dehydration and hypovolemia, we arrive at another critical danger: the exacerbation of Acute Kidney Injury (AKI). Your kidneys are absolute workhorses, constantly filtering your blood, regulating fluid and electrolytes, and removing waste products. But like any vital organ, they have their limits, and they are particularly vulnerable to sudden drops in blood flow and volume.
When you're dehydrated and hypovolemic, the blood flow to your kidneys decreases. This is called pre-renal AKI, and it's essentially your kidneys "drying up" because they're not getting enough fluid to do their job properly. Now, factor in the stress of surgery. The inflammatory response, the release of stress hormones, and the potential for blood pressure fluctuations during anesthesia all place additional strain on the kidneys. Certain anesthetic agents or other medications given during surgery can also be nephrotoxic (toxic to the kidneys) in susceptible individuals.
Jardiance significantly amplifies this risk. By already promoting fluid loss and potentially reducing circulating blood volume, it primes the kidneys for injury. When this baseline vulnerability is combined with the NPO status, the surgical stress, and the fluid shifts inherent to the procedure, the likelihood of developing AKI skyrockets. The kidneys, already working hard and slightly depleted, simply cannot withstand the additional insult. This isn't just a minor inconvenience; AKI is a serious complication that can lead to prolonged hospital stays, increased morbidity, and in severe cases, the need for dialysis or even permanent kidney damage.
Patients with pre-existing kidney disease, even mild forms, are at an even higher risk. While Jardiance is beneficial for chronic kidney disease in the long term, its acute effects in the perioperative period can be detrimental. It's a classic example of a medication that's a friend in the long run but can be a foe in the short-term, acute setting of surgery. Preventing Jardiance AKI risk and SGLT2 kidney injury surgery is a major reason for holding the drug, ensuring that these vital organs are given the best possible chance to weather the surgical storm.
Keyword Focus: Jardiance AKI risk, SGLT2 kidney injury surgery, acute kidney injury perioperative.
Impact on Blood Pressure and Anesthetic Management
Finally, let's talk about blood pressure and its intimate relationship with anesthetic management. This is where many of the previously discussed risks converge and create direct challenges for the team keeping you safe during surgery. Jardiance, as we know, can lower blood pressure. This is often a desired effect, especially in patients with hypertension or heart failure. However, in the surgical suite, this effect can become a significant problem.
Anesthesia itself is a potent modulator of blood pressure. Most anesthetic agents cause some degree of vasodilation, meaning they relax the blood vessels, leading to a drop in systemic vascular resistance and, consequently, blood pressure. For a patient with normal blood volume and healthy cardiovascular reflexes, the body can usually compensate, and the anesthesiologist can manage these drops with fluids or medications that constrict blood vessels (vasopressors).
However, consider a patient who has been taking Jardiance. They likely have a lower baseline blood pressure due to the drug's effects. They are also at increased risk of dehydration and hypovolemia, which further predisposes them to low blood pressure. Now, introduce anesthetic agents into this already precarious situation. The combination can lead to a profound and precipitous drop in blood pressure that is much harder to manage. This severe hypotension (low blood pressure) can compromise blood flow to vital organs – the brain, the heart, and the kidneys – potentially leading to stroke, heart attack, or acute kidney injury, as we just discussed.
The anesthesiologist's job is to maintain hemodynamic stability – keeping your blood pressure, heart rate, and oxygen levels within safe parameters throughout the procedure. When a patient is already predisposed to hypotension due to Jardiance, their "buffer" is reduced, making their system much more fragile. It means the anesthesiologist has fewer margins for error, and every decision becomes more critical. They might need to administer more fluids, which can have its own risks, or use stronger vasopressors, which can also have side effects. The goal is always to keep you safe and stable, and removing Jardiance from the equation simplifies this complex task significantly, allowing for smoother and safer anesthetic management. It’s about minimizing variables and maximizing control in an environment where precision is paramount.
Keyword Focus: Jardiance blood pressure, SGLT2 hypotension surgery, anesthetic management risks.
When to Hold Jardiance: The Golden Rules
So, we've established the "why." Now, let's tackle the "when." This isn't a nebulous guideline; there are clear, evidence-based recommendations for holding Jardiance before surgery. It's a critical piece of information that needs to be communicated clearly between you, your primary care doctor, your endocrinologist (if you have one), and your surgical team. Skipping this step, or getting the timing wrong, can invite those risks we just painstakingly detailed.
Current Recommendations: Timing is Everything
The consensus among major medical organizations – including the American Association of Clinical Endocrinologists (AACE), the American Diabetes Association (ADA), and various anesthesiology societies – is quite clear: Jardiance (empagliflozin) should be discontinued several days before elective surgery. The exact timing can vary slightly based on the specific SGLT2 inhibitor and individual patient factors, but the general rule of thumb is to stop it at least 3-4 days prior to surgery.
For Jardiance specifically, the most commonly cited recommendation is to hold it for at least 3 days (72 hours) before any elective surgical procedure or other situations involving prolonged fasting, significant fluid loss, or major medical stress. Some guidelines even push for 4 days (96 hours) for an added margin of safety, especially in patients at higher risk for eDKA or AKI. This timeframe allows the drug to be sufficiently cleared from your system, minimizing its effects on glucose excretion, fluid balance, and ketone production when you enter the perioperative period. It's not about stopping it the morning of surgery; it's about giving your body time to reset its metabolic equilibrium.
It's crucial to understand that this isn't a casual suggestion. This is a directive born from adverse events and rigorous research. The half-life of Jardiance is approximately 12 hours, meaning it takes about 5-6 half-lives for the drug to be almost entirely eliminated from your system. Three to four days gives ample time for this elimination process, significantly reducing the circulating levels of the drug and, consequently, its problematic effects on your kidneys and metabolism. Any less time, and you risk entering surgery with residual drug activity, leaving you vulnerable to eDKA, dehydration, and hemodynamic instability.
This recommendation also applies to other SGLT2 inhibitors like canagliflozin (Invokana), dapagliflozin (Farxiga), and ertugliflozin (Steglatro), although the exact number of days might differ slightly based on their individual pharmacokinetic profiles. The overarching principle remains the same: these drugs need to be stopped well in advance to prevent severe perioperative complications. Always consult your surgical team and prescribing physician for the precise timing tailored to your specific situation and the type of surgery you are undergoing.
Keyword Focus: holding Jardiance before surgery, when to stop Jardiance, SGLT2 inhibitor hold time, Jardiance perioperative guidelines.
What About Emergency Surgery?
"Okay," you might be thinking, "that's great for elective surgery, but what if it's an emergency? What if I'm rushed in and there's no time to hold the medication?" That's a very valid and important question, and the answer, while more challenging, still revolves around awareness and rapid intervention.
In the case of emergency surgery, where there isn't the luxury of 3-4 days to discontinue Jardiance, the medical team needs to be immediately aware that you are on an SGLT2 inhibitor. This information is absolutely critical for the anesthesiologist and the surgical team. It means they will be on high alert for the signs and symptoms of eDKA, profound dehydration, and acute kidney injury. They will proactively monitor your blood glucose, blood gases (to check for acidosis), and ketone levels, even if your blood sugar appears normal.
Management in an emergency scenario would involve aggressive intravenous fluid administration to combat dehydration and maintain blood pressure. If eDKA is suspected or diagnosed, treatment involves insulin therapy (even if blood glucose is normal), fluid resuscitation, and electrolyte correction. The key here is early recognition and aggressive management. The risk is significantly higher in an emergency setting because the preparatory "holding period" has been bypassed, so the vigilance of the medical team becomes paramount.
This underscores the importance of always informing all healthcare providers about all your medications, especially in an emergency. Wearing a medical alert bracelet or carrying a medication list can literally be a lifesaver. While you can't plan to hold Jardiance for an emergency, you can plan to ensure the medical team is fully informed so they can anticipate and mitigate the risks associated with its acute presence in your system. This proactive communication is your best defense in an unplanned surgical event.
Keyword Focus: Jardiance emergency surgery, SGLT2 inhibitors urgent surgery, managing Jardiance in emergencies.
The Role of Communication: Your Safety Net
In the intricate dance of perioperative care, communication isn't just a courtesy; it's the bedrock of patient safety. You, as the patient, are a crucial member of your healthcare team, and your active participation in communicating your medication regimen is your ultimate safety net. Never underestimate the power of clear, consistent information sharing.
Informing Your Healthcare Team: Who Needs to Know?
This might seem obvious, but it bears repeating with emphasis: everyone involved in your surgical care needs to know you are taking Jardiance. This includes:
- Your Primary Care Physician (PCP): They are usually the first point of contact and can help coordinate medication adjustments.
- Your Endocrinologist (if applicable): They manage your diabetes or other endocrine conditions and are experts in these medications. They should be involved in the plan for holding Jardiance and managing your blood sugar during the holding period.
- Your Surgeon: They need to be aware of all medications to understand potential surgical risks and plan accordingly.
- The Anesthesiologist: This is arguably the most critical person to inform. They are directly responsible for managing your physiological state during surgery and need to anticipate how Jardiance might affect anesthesia and your body's responses.
- Nurses and Other Hospital Staff: They will be monitoring you before, during, and after surgery. They need to know what medications you're on and what to look out for.
Pro-Tip: The Medication List Power-Up
Always carry an up-to-date list of all your medications, including doses, frequency, and why you take them. Highlight Jardiance (or any SGLT2 inhibitor) and make a note about the need to hold it before surgery. This simple act can save precious time and prevent errors, especially in an emergency.
Keyword Focus: communicating medication list, informing surgical team Jardiance, patient advocacy surgery.
Managing Blood Sugar During the Holding Period
"Okay, so I stop Jardiance. But what about my blood sugar? Won't it go up?" Absolutely, this is a very common and legitimate concern. Jardiance is doing a job, and when it stops, your blood sugar will likely rise. This is why simply stopping the drug isn't the whole plan; there needs to be a strategy to manage your blood glucose during the holding period.
Your endocrinologist or primary care physician, in consultation with the surgical team, will develop a temporary plan. This usually involves:
- Temporary Insulin Adjustments: If you're on insulin, your doses might be increased or changed to a different type of insulin (e.g., switching to a basal-bolus regimen if you're not already on one).
- Other Oral Hypoglycemic Agents: Some patients might be temporarily switched to different oral diabetes medications that do not carry the same perioperative risks as SGLT2 inhibitors. Metformin, for example, is often continued until the day of surgery, though it also has its own specific perioperative considerations (risk of lactic acidosis).
- Increased Blood Glucose Monitoring: You will likely be asked to check your blood sugar more frequently at home during the days leading up to surgery. This allows for prompt adjustments to your temporary
